Selectis Health (GBCS) Cash from Financing Activities (2010 - 2025)

Selectis Health has disclosed Cash from Financing Activities across 16 years of filings, most recently posting $42335.0 for Q4 2025.

• Cash from Financing Activities for Q4 2025 came in at $42335.0, up 1549.2% year-over-year; the trailing twelve-month figure through Dec 2025 was -$976692.0 (up 36.46% YoY), and the FY2025 annual result was -$976692.0, up 36.46% from the prior year.
• Cash from Financing Activities came in at $42335.0 for Q4 2025 at Selectis Health, up from -$383707.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $1.1 million in Q4 2023 to a low of -$1.0 million in Q3 2023.
• The 5-year median for Cash from Financing Activities is -$171808.0 (2024), against an average of -$168808.8.
• Across the five-year window, Cash from Financing Activities sank 765.7% in 2022 and jumped 1549.2% in 2025, its largest moves.
• Selectis Health's Cash from Financing Activities stood at -$128705.0 in 2021, then plunged by 519.61% to -$797467.0 in 2022, then soared by 236.62% to $1.1 million in 2023, then tumbled by 99.76% to $2567.0 in 2024, then surged by 1549.2% to $42335.0 in 2025.
• The last three Cash from Financing Activities figures came in at $42335.0 (Q4 2025), -$383707.0 (Q3 2025), and -$452881.0 (Q2 2025), per Business Quant data.